Medical Advisory Board

The Medical Advisory Board is comprised of experts in the field of medical oncology, interventional radiology, hepatobilary surgery, and vascular surgery. The Board represents the multidisciplinary nature of the current interventional oncology space.

Govindarajan Narayanan, M.D - Interventional Oncologist
Govindarajan Narayanan, M.D., is a Professor of Radiology at the Herbert Wertheim College of Medicine, Florida International University. He is the Chief of Interventional Oncology at the Miami Cancer Institute, and practices at the Miami Cardiac & Vascular Institute, both part of Baptist Health of South Florida.

Prof Stephen Clarke - Medical OncologistStephen Clarke is a medical oncologist, pharmacologist, and translational researcher with major clinical and research interests in gastrointestinal and thoracic cancers and pharmacology. Stephen was awarded an… — Prof Stephen Clarke - Medical Oncologist
Stephen Clarke is a medical oncologist, pharmacologist, and translational researcher with major clinical and research interests in gastrointestinal and thoracic cancers and pharmacology. Stephen was awarded an OAM for services to medicine in the disciplines of oncology and pharmacology. Stephen has been critical to the development of AllVascular’s clinical trials and strategy.

A/Prof Nick Pavlakis - Medical OncologistNick is the president elect of the Clinical Oncology Society of Australia (COSA).  He is an expert in upper gastrointestinal and lung cancers. Nick designed the AllVascular sponsored Phase Ib/II colorect… — A/Prof Nick Pavlakis - Medical Oncologist
Nick is the president elect of the Clinical Oncology Society of Australia (COSA). He is an expert in upper gastrointestinal and lung cancers. Nick designed the AllVascular sponsored Phase Ib/II colorectal liver cancer trial and was the key advisor in designing the initial feasibility/safety trial. Nick has also been instrumental in helping the team to develop the AllVascular sponsored Phase Ib/II pancreatic cancer trial.

Prof Thomas Hugh – Hepatobiliary SurgeonTom is the Head of the Upper GI Surgical Unit at RNSH, Chair of Surgery at the Northern Clinical School, Director RNSH SERT Institute and a Board Member of the CanSur Foundation. He provides critical surgical … — Prof Thomas Hugh – Hepatobiliary Surgeon
Tom is the Head of the Upper GI Surgical Unit at RNSH, Chair of Surgery at the Northern Clinical School, Director RNSH SERT Institute and a Board Member of the CanSur Foundation. He provides critical surgical knowledge for trial design with the intent to downgrade more patients to resection. He provides guidance to oncologists in assessing the resectability of tumours.

Prof Rodney Lane - Vascular SurgeonProfessor Rodney Lane is Senior Vascular Surgeon at Royal North Shore Hospital. He is also at Sydney Adventist Hospital and Macquarie University Hospital in Sydney. He holds the chair of Vascular Research at Macqua… — Prof Rodney Lane - Vascular Surgeon
Professor Rodney Lane is Senior Vascular Surgeon at Royal North Shore Hospital. He is also at Sydney Adventist Hospital and Macquarie University Hospital in Sydney. He holds the chair of Vascular Research at Macquarie University. Professor Lane has been involved in numerous vascular research projects over the past 45 years, with the majority focussing on novel Bioengineering approaches.

Dr Chris Rogan – Interventional RadiologistChris is currently a VMO and Director of Training at RPAH Radiology with his focus on Interventional Oncology, Embolisation and Endovascular surgery. He administered the AVAS® treatments in the safety/feasi… — Dr Chris Rogan – Interventional Radiologist
Chris is currently a VMO and Director of Training at RPAH Radiology with his focus on Interventional Oncology, Embolisation and Endovascular surgery. He administered the AVAS® treatments in the safety/feasibility colorectal liver trial. He provides expertise in organ isolation and directed therapies which are critical for the development of the clinical trial protocols.

A/Prof Gavin Marx - Medical OncologistGavin is the director of the Sydney Adventist Hospital Clinical Trials Unit. Gavin is an expert in gastrointestinal and prostate cancers. He designed the Phase Ib/II colorectal liver cancer trial with Prof … — A/Prof Gavin Marx - Medical Oncologist
Gavin is the director of the Sydney Adventist Hospital Clinical Trials Unit. Gavin is an expert in gastrointestinal and prostate cancers. He designed the Phase Ib/II colorectal liver cancer trial with Prof Pavlakis. Gavin’s knowledge will be critical when exploring further applications of the AVAS® device particularly in the pelvis.